I forget who sent me a copy of Abortion and the Conscience of the Nation in early 1984, but I do remember that it was one of the first, perhaps the first, pro-life books that I had ever read. I had returned to the U.S.
I was waiting at Kaiser to see a doctor had never met before. As I waited I became aware of a need to pray. There were doctors and patients in all the examination rooms that surrounded me. My guardian angel must be nudging me to
Abortion is illegal throughout Latin America. The only countries which allow it are Cuba and — because it is under U.S. law — Puerto Rico. But the death peddlers, to use Fr. Marx’s phrase, are daily becoming more aggressive. To combat this growing threat, PRI
23 de Abril del 2004 Volumen 6/Número 16 Estimado amigo: USAID está pidiendo terminar con la promiscuidad sexual en el extranjero, con el objeto de detener la expansión del HIV/SIDA. Al mismo tiempo, sin embargo, USAID está promoviendo la promiscuidad sexual bajo la modalidad de
April 23, 2004 Volume 6 / Number 16 Dear Colleague: USAID is calling for an end to sexual promiscuity overseas, in order to stop the spread of HIV/AIDS. At the same time, however, USAID is promoting sexual promiscuity in the form of over-the-counter distribution of
April 16, 2004 Volume 6 / Number 15 Dear Colleague: Over-the-counter (OTC) availability of the morning-after pill (MAP)-so called “emergency contraception” or EC- would increase rates of abortion, disease, sexual promiscuity, and sexual violence committed against American teens. OTC/MAP means danger for American girls. Steven
April 8, 2004 Volume 6 / Number 14 Dear Colleague: A new report by the U.S. Census Bureau warns that the rate of world population growth is continuing to fall. Mortality rates increase. Fertility rates continue to fall. Population collapse is just around the corner.
April 2, 2004 Volume 6 / Number 13 Dear Colleague: The efforts to pressure the U.S. Food and Drug Administration (FDA) into approving the morning-after pill (MAP) for over-the-counter (OTC) distribution are inextricably linked to the international abortion industry. The founder of Women’s Capital Corporation,
Press Release Source: Population Reseach New Report on FDA Approval of ‘Emergency Contraception’ WASHINGTON, DC, 31 March 2004 — Population Research Institute has released an in-depth report on so-called “emergency contraception.” The U.S. Food and Drug Administration (FDA) has delayed its decision to act on
March 26, 2004 Volume 6 / Number 12 Dear Colleague: On February 20, 2004, the Food and Drug Administration (FDA) announced it would delay for 90 days its decision to approve over-the-counter (OTC) status of the morning-after pill (MAP). The FDA said it needed more
I forget who sent me a copy of Abortion and the Conscience of the Nation in early 1984, but I do remember that it was
I was waiting at Kaiser to see a doctor had never met before. As I waited I became aware of a need to pray. There
Abortion is illegal throughout Latin America. The only countries which allow it are Cuba and — because it is under U.S. law — Puerto Rico.
23 de Abril del 2004 Volumen 6/Número 16 Estimado amigo: USAID está pidiendo terminar con la promiscuidad sexual en el extranjero, con el objeto de
April 23, 2004 Volume 6 / Number 16 Dear Colleague: USAID is calling for an end to sexual promiscuity overseas, in order to stop the
April 16, 2004 Volume 6 / Number 15 Dear Colleague: Over-the-counter (OTC) availability of the morning-after pill (MAP)-so called “emergency contraception” or EC- would increase
April 8, 2004 Volume 6 / Number 14 Dear Colleague: A new report by the U.S. Census Bureau warns that the rate of world population
April 2, 2004 Volume 6 / Number 13 Dear Colleague: The efforts to pressure the U.S. Food and Drug Administration (FDA) into approving the morning-after
Press Release Source: Population Reseach New Report on FDA Approval of ‘Emergency Contraception’ WASHINGTON, DC, 31 March 2004 — Population Research Institute has released an
March 26, 2004 Volume 6 / Number 12 Dear Colleague: On February 20, 2004, the Food and Drug Administration (FDA) announced it would delay for